Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taekwang Pharmaceutical is a South Korean pharmaceutical company founded in 1956 that specializes in the development and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company maintains a diverse portfolio of over 100 products, focusing on therapeutic areas such as respiratory, cardiovascular, gastrointestinal, and metabolic health. Operating out of its KGMP-certified manufacturing facilities in Hwaseong, Taekwang provides a steady supply of essential generic medicines and over-the-counter (OTC) products to the domestic Korean market. The company is also active in international trade, exporting its pharmaceutical products to several countries across Asia and other regions. Taekwang Pharmaceutical is recognized for its long history of reliability in the Korean healthcare sector and its commitment to providing affordable medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taekwang.